This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2007.04.084v1 50/10/917    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boden, W. E. Articles by Granger, C. B. Search for Related Content PubMed PubMed Citation Articles by Boden, W. E. Articles by Granger, C. B.

STATE-OF-THE-ART PAPER

Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction

A Comprehensive Review of Contemporary Management Options

William E. Boden, MD, FACC^_*,_*, Kim Eagle, MD, FACC and Christopher B. Granger, MD, FACC

^_* School of Medicine and Biomedical Sciences, State University of New York, and Kaleida Health System, Buffalo, New York
University of Michigan Cardiovascular Center, Ann Arbor, Michigan
Division of Cardiology, Duke University Medical Center, Durham, North Carolina

Manuscript received February 6, 2007; revised manuscript received April 25, 2007, accepted April 30, 2007.

^_* Reprint requests and correspondence: Dr. William E. Boden, Chief of Cardiology, Buffalo General and Millard Fillmore Hospitals, 100 High Street, Buffalo, New York 14203. (Email: wboden{at}kaleidahealth.org).

There are an estimated 500,000 ST-segment elevation myocardial infarction (STEMI) events in the U.S. annually. Despite improvements in care, up to one-third of patients presenting with STEMI within 12 h of symptom onset still receive no reperfusion therapy acutely. Clinical studies indicate that speed of reperfusion after infarct onset may be more important than whether pharmacologic or mechanical intervention is used. Primary percutaneous coronary intervention (PCI), when performed rapidly at high-volume centers, generally has superior efficacy to fibrinolysis, although fibrinolysis may be more suitable for many patients as an initial reperfusion strategy. Because up to 70% of STEMI patients present to hospitals without on-site PCI facilities, and prolonged door-to-balloon times due to inevitable transport delays commonly limit the benefit of PCI, the continued role and importance of the prompt, early use of fibrinolytic therapy may be underappreciated. Logistical complexities such as triage or transportation delays must be considered when a reperfusion strategy is selected, because prompt fibrinolysis may achieve greater benefit, especially if the fibrinolytic-to-PCI time delay associated with transfer exceeds 1 h. Selection of a fibrinolytic requires consideration of several factors, including ease of dosing and combination with adjunctive therapies. Careful attention to these variables is critical to ensuring safe and rapid reperfusion, particularly in the prehospital setting. The emerging modality of pharmacoinvasive therapy, although controversial, seeks to combine the benefits of mechanical and pharmacologic reperfusion. Results from ongoing clinical trials will provide guidance regarding the utility of this strategy.

Abbreviations and Acronyms   ACC = American College of Cardiology   AHA = American Heart Association   ECG = electrocardiogram   ED = emergency department   EMS = emergency medical services   MI = myocardial infarction   NRMI = National Registry of Myocardial Infarction   PCI = percutaneous coronary intervention   STEMI = ST-segment elevation myocardial infarction   TIMI = Thrombolysis In Myocardial Infarction

This article has been cited by other articles:

				D. S. Pinto, P. D. Frederick, A. K. Chakrabarti, A. J. Kirtane, E. Ullman, A. Dejam, D. P. Miller, T. D. Henry, C. M. Gibson, and for the National Registry of Myocardial Infarction Benefit of Transferring ST-Segment-Elevation Myocardial Infarction Patients for Percutaneous Coronary Intervention Compared With Administration of Onsite Fibrinolytic Declines as Delays Increase Circulation, December 6, 2011; 124(23): 2512 - 2521. [Abstract] [Full Text] [PDF]

				E. D. Folland 16.13.6 Percutaneous interventional cardiac procedures OTM, November 30, 2011; 5(1): med-9780199204854-chapter - med-9780199204854-chapter. [Abstract] [Full Text]

				M. V. Sorensen, S. Pedersen, R. Mogelvang, J. Skov-Jensen, and A. Flyvbjerg Plasma High-Mobility Group Box 1 Levels Predict Mortality After ST-Segment Elevation Myocardial Infarction J. Am. Coll. Cardiol. Intv., March 1, 2011; 4(3): 281 - 286. [Abstract] [Full Text] [PDF]

				M. P. Hudson, P. W. Armstrong, W. W. O'Neil, A. L. Stebbins, W. D. Weaver, P. Widimsky, P. E. Aylward, W. Ruzyllo, D. Holmes, K. W. Mahaffey, et al. Mortality Implications of Primary Percutaneous Coronary Intervention Treatment Delays: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction Trial Circ Cardiovasc Qual Outcomes, March 1, 2011; 4(2): 183 - 192. [Abstract] [Full Text] [PDF]

				L. M. Biasucci and R. Della Bona Prognostic Biomarkers in ST-Segment Elevation Myocardial Infarction: A Step Toward Personalized Medicine or a Tool in Search of an Application? J. Am. Coll. Cardiol., January 4, 2011; 57(1): 37 - 39. [Full Text] [PDF]

				J. Oldgren, L. Wernroth, U. Stenestrand, and on behalf of the RIKS-HIA registry, Sweden Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIA Heart, September 1, 2010; 96(18): 1451 - 1457. [Abstract] [Full Text] [PDF]

				Y. B. Pride, P. Tung, S. Mohanavelu, C. Zorkun, S. D. Wiviott, E. M. Antman, R. Giugliano, E. Braunwald, C. M. Gibson, and for the TIMI Study Group Angiographic and Clinical Outcomes Among Patients With Acute Coronary Syndromes Presenting With Isolated Anterior ST-Segment Depression: A TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) Substudy J. Am. Coll. Cardiol. Intv., August 1, 2010; 3(8): 806 - 811. [Abstract] [Full Text] [PDF]

				M. Siriwardena, T. Kleffmann, P. Ruygrok, V. A. Cameron, T. G. Yandle, M. G. Nicholls, A. M. Richards, and C. J. Pemberton B-Type Natriuretic Peptide Signal Peptide Circulates in Human Blood: Evaluation as a Potential Biomarker of Cardiac Ischemia Circulation, July 20, 2010; 122(3): 255 - 264. [Abstract] [Full Text] [PDF]

				G. A. Lamas, E. Escolar, and D. P. Faxon Review Article: Examining Treatment of ST-Elevation Myocardial Infarction: The Importance of Early Intervention Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2010; 15(1): 6 - 16. [Abstract] [PDF]

				S. H. Pedersen, S. Galatius, P. R. Hansen, R. Mogelvang, S. Z. Abildstrom, R. Sorensen, U. Davidsen, A. Galloe, U. Abildgaard, A. Iversen, et al. Field Triage Reduces Treatment Delay and Improves Long-Term Clinical Outcome in Patients With Acute ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2296 - 2302. [Abstract] [Full Text] [PDF]

				C. Hagl, N. Khaladj, S. Peterss, A. Martens, I. Kutschka, H. Goerler, M. Shrestha, and A. Haverich Acute Treatment of ST-Segment-Elevation Myocardial Infarction: Is There a Role for the Cardiac Surgeon? Ann. Thorac. Surg., December 1, 2009; 88(6): 1786 - 1792. [Abstract] [Full Text] [PDF]

				W. Jintapakorn, A. Lim, T. Yipintsoi, W. Moleerergpoom, S. Srimahachota, and O. Sriyadthasak Consequence and Factors Related to Not Offering Reperfusion Therapy in STEMI Angiology, December 1, 2009; 60(6): 689 - 697. [Abstract] [PDF]

				A. Halkin, D. Fourey, A. Roth, V. Boyko, and S. Behar Incidence and prognosis of non-Q-wave vs. Q-wave myocardial infarction following catheter-based reperfusion therapy QJM, June 1, 2009; 102(6): 401 - 406. [Abstract] [Full Text] [PDF]

				N. Gonzalo, P. Barlis, P. W. Serruys, H. M. Garcia-Garcia, Y. Onuma, J. Ligthart, and E. Regar Incomplete Stent Apposition and Delayed Tissue Coverage Are More Frequent in Drug-Eluting Stents Implanted During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Than in Drug-Eluting Stents Implanted for Stable/Unstable Angina: Insights From Optical Coherence Tomography J. Am. Coll. Cardiol. Intv., May 1, 2009; 2(5): 445 - 452. [Abstract] [Full Text] [PDF]

				C J Terkelsen, E H Christiansen, J T Sorensen, S D Kristensen, J F Lassen, L Thuesen, H R Andersen, W Vach, and T T Nielsen Primary PCI as the preferred reperfusion therapy in STEMI: it is a matter of time Heart, March 1, 2009; 95(5): 362 - 369. [Abstract] [Full Text] [PDF]

				T Shiga, N Hagiwara, H Ogawa, A Takagi, M Nagashima, T Yamauchi, Y Tsurumi, R Koyanagi, H Kasanuki, and for the Heart Institute of Japan Acute Myocardial Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: results from the HIJAMI-II registry Heart, February 1, 2009; 95(3): 216 - 220. [Abstract] [Full Text] [PDF]

				P. Menasche Chapter 10 Stem Cell Therapy Post-AMI Cardiac Protection, January 1, 2009; 1(1): med-9780199544769-chapter - med-9780199544769-chapter. [Abstract] [Full Text]

				C. J. Terkelsen and T. T. Nielsen Reperfusion Strategies in Acute ST-Segment Elevation Myocardial Infarction: Acute Angioplasty May Be Feasible for the Majority of U.S. Citizens J. Am. Coll. Cardiol., September 9, 2008; 52(11): 966 - 967. [Full Text] [PDF]

				W. E. Boden Reply J. Am. Coll. Cardiol., September 9, 2008; 52(11): 967 - 968. [Full Text] [PDF]

				C. J. Terkelsen and J. F. Lassen Treatment delays in ST elevation myocardial infarction BMJ, February 23, 2008; 336(7641): 401 - 402. [Full Text] [PDF]